<b>Experiences of transgender youths in health care</b>

1h

Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial

Nature Medicine, Published online: 04 August 2021; doi:10.1038/s41591-021-01453-zA new randomized, crossover clinical trial testing rapid-acting insulin aspart delivered in a closed-loop system compared with standard care demonstrates increased time in range in patients with type 2 diabetes who require dialysis in the outpatient setting.

18h

Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial

21h

Remove obstacles to sharing health data with researchers outside of the European Union

Nature Medicine, Published online: 02 August 2021; doi:10.1038/s41591-021-01460-0COVID-19 has shown that international collaborations and global data sharing are essential for health research, but legal obstacles are preventing data sharing for non–pandemic-related research among public researchers across the world, with potentially damaging effects...

1d

Remove obstacles to sharing health data with researchers outside of the European Union

2d

Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial

Nature Medicine, Published online: 02 August 2021; doi:10.1038/s41591-021-01444-0Interim analysis from the randomized phase 3 JUPITER-02 trial shows that the addition of anti-PD-1 toripalimab to standard gemcitabine/cisplatin as a first-line treatment for patients with recurrent or metastatic nasopharyngeal carcinoma has manageable toxicity and improves...

2d

Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial

2d

Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial

Nature Medicine, Published online: 30 July 2021; doi:10.1038/s41591-021-01469-5In a large prospective phase 4 trial, vaccination with CoronaVac, an inactivated SARS-CoV-2 vaccine, elicited significantly lower virus-specific IgG antibodies and neutralizing antibodies in patients with autoimmune rheumatic diseases than in age- and sex-matched healthy...

5d

Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial

6d

Melding microbiome and nutritional science with early child development

Nature Medicine, Published online: 29 July 2021; doi:10.1038/s41591-021-01451-1Programs for treating malnutrition in children should consider how food formulations affect postnatal gut microbiome development.

6d